Sinofn Health
Sinofn Health
In the rapidly evolving global nutraceutical market, brands are shifting from simple private labeling to evidence-based product development. SINOFN Health Co., Ltd., born from the prestige of the Chinese Academy of Sciences in 2012, operates at the intersection of clinical nutrition and industrial-scale manufacturing. We do not just supply products; we provide a Technical Roadmap for brands to navigate the complexities of modern supplement formulation.
The nutraceutical landscape faces two major challenges: the demand for transparent "Clean Label" products and the stringent regulatory requirements across different geographic regions (FDA, EU EFSA, NMPA). SINOFN solves this through a integrated supply chain that spans from raw material sourcing—leveraging our deep research into jujube extracts and tremella polysaccharides—to state-of-the-art GMP-certified production facilities.
Director of Medical Innovation. With 15+ years of experience in metabolic disorder formulations, Dr. Tan leads our pivot toward FSMP (Foods for Special Medical Purposes), ensuring our formulations are clinically validated before they reach the production line.
CAS Postdoc and R&D Lead. Specialized in bioactive compound delivery systems. Dr. Zhang ensures that our NMN, cAMP, and peptide products maintain peak bioavailability—a critical differentiator in premium market segments.
Senior Formulation Director. With European expertise, Hans manages our compliance frameworks, ensuring all OEM outputs meet rigorous international quality standards, from label claim accuracy to microbiological safety.
Our roadmap emphasizes "Bio-Integration." We utilize pilot-scale prototyping to validate stability, bioavailability, and dissolution rates before full-scale manufacturing, mitigating risks for our startup and enterprise partners.
Navigating Global Markets: Our manufacturing facility in Tianjin is ISO 22000, HACCP, and FSSC 22000 certified. This enables us to provide "Audit-Ready" documentation for global clients, whether you are entering the North American market with Vitamin C formulations or the European market with advanced NMN/NAD+ precursors.
Application Scenarios:
We leverage our partnership with the Chinese Academy of Sciences to conduct pilot runs. We assess stability, taste, and bioavailability before finalizing your custom formulation.
Yes, our facility is designed for scalability. We offer flexible MOQ solutions that allow new brands to enter the market without excessive inventory risk, while providing the same quality guarantees as large-scale enterprise production.
From concept to sample, we typically operate on a 4-8 week timeline, depending on the complexity of the formulation and testing requirements.
